Povidone-iodine is a stable chemical complex of polyvinylpyrrolidone (povidone, PVP) and elemental iodine. It contains from 9.0% to 12.0% available iodine, calculated on a dry basis. This unique complex was discovered in 1955 at the Industrial Toxicology Laboratories in Philadelphia by H. A. Shelanski and M. V. Shelanski. During in vitro testing to demonstrate anti-bacterial activity it was found that the complex was less toxic in mice than tincture of iodine. Human clinical trials showed the product to be superior to other iodine formulations. Povidone-iodine was immediately marketed, and has since become the universally preferred iodine antiseptic.
For topical application in the treatment and prevention of infection in wounds.
University Hospital, Newark, New Jersey, United States
Ophthalmology clinic, Shaare Zedek Medical Center, Jerusalem, Israel
St. Joseph's Healthcare, Hamilton, Ontario, Canada
Montreal General Hospital, Montreal, Quebec, Canada
St. Mary's Hospital, Montreal, Quebec, Canada
Bascom Palmer Eye Institute, Palm Beach Gardens, Florida, United States
Medical Center Ophthalmology Associates, San Antonio, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Eva Lopezosa Reca, Málaga, Spain
Alexandria University Faculty of Medicine, Alexandria, Egypt
St Olavs Hospital, Trondheim, Norway
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.